LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 191

Search options

  1. Article: [Preface].

    Ago, Yukio / Mouri, Akihiro

    Nihon yakurigaku zasshi. Folia pharmacologica Japonica

    2023  Volume 158, Issue 3, Page(s) 228

    Language Japanese
    Publishing date 2023-04-28
    Publishing country Japan
    Document type Journal Article
    ZDB-ID 1097532-9
    ISSN 1347-8397 ; 0015-5691
    ISSN (online) 1347-8397
    ISSN 0015-5691
    DOI 10.1254/fpj.22151
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Chronic social defeat stress induces anxiety-like behaviors via downregulation of serotonin transporter in the prefrontal serotonergic system in mice.

    Araki, Ryota / Kita, Ayami / Ago, Yukio / Yabe, Takeshi

    Neurochemistry international

    2024  Volume 174, Page(s) 105682

    Abstract: The serotonergic (5-HTergic) system is closely involved in the pathophysiology of mood and anxiety disorders and the responsibility of this system may differ for each symptom. In this study, we examined the relationship between the dysfunction of the 5- ... ...

    Abstract The serotonergic (5-HTergic) system is closely involved in the pathophysiology of mood and anxiety disorders and the responsibility of this system may differ for each symptom. In this study, we examined the relationship between the dysfunction of the 5-HTergic system and abnormal behaviors in the social defeat stress model, an animal model of mood and anxiety disorders and in mice with knockdown of Slc6a4, the gene encoding SERT. Monoamine content, serotonin (5-HT) release, 5-HT uptake, 5-HT transporter (SERT) protein levels, and behaviors were investigated in mice subjected to chronic social defeat stress and in mice with knockdown of Slc6a4, in 5-HTergic neurons projecting to the prefrontal cortex (PFC). Furthermore, DNA methylation of Slc6a4 was examined in mice subjected to chronic social defeat stress. Increased turnover, increased extracellular basal levels, decreased release and decreased uptake of 5-HT, and decreased SERT protein levels were observed in the PFC of the stressed mice. The decreased 5-HT uptake correlated with anxiety-like behavior characterized by decreased time spent in the open arms of the elevated plus maze. DNA methylation was increased in the CpG island of Slc6a4 in 5-HTergic neurons projecting to the PFC of the stressed mice. Similar to the stressed mice, mice with Slc6a4 knockdown in 5-HTergic neurons projecting to the PFC also showed decreased release and uptake of 5-HT in the PFC and increased anxiety-like behavior. Chronic stress may induce anxiety due to dysfunction in the prefrontal 5-HTergic system via decreased SERT expression in the PFC.
    MeSH term(s) Mice ; Animals ; Serotonin Plasma Membrane Transport Proteins/genetics ; Serotonin Plasma Membrane Transport Proteins/metabolism ; Serotonin/metabolism ; Down-Regulation ; Social Defeat ; Anxiety ; Prefrontal Cortex/metabolism
    Chemical Substances Serotonin Plasma Membrane Transport Proteins ; Serotonin (333DO1RDJY)
    Language English
    Publishing date 2024-02-01
    Publishing country England
    Document type Journal Article
    ZDB-ID 283190-9
    ISSN 1872-9754 ; 0197-0186
    ISSN (online) 1872-9754
    ISSN 0197-0186
    DOI 10.1016/j.neuint.2024.105682
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: [Development of the vasoactive intestinal peptide receptor 2 (VIPR2) antagonist peptide for the treatment of schizophrenia].

    Ago, Yukio / Asano, Satoshi / Sakamoto, Kotaro

    Nihon yakurigaku zasshi. Folia pharmacologica Japonica

    2023  Volume 158, Issue 3, Page(s) 242–245

    Abstract: Schizophrenia affects approximately 24 million people worldwide. Existing medications for the treatment of schizophrenia work primarily by improving positive symptoms such as agitation, hallucinations, delusions, and aggression. They possess common ... ...

    Abstract Schizophrenia affects approximately 24 million people worldwide. Existing medications for the treatment of schizophrenia work primarily by improving positive symptoms such as agitation, hallucinations, delusions, and aggression. They possess common mechanism of action (MOA), blocking to neurotransmitter receptors such as dopamine, serotonin, and adrenaline receptors. Although multiple agents are available for the treatment of schizophrenia, the majority do not address negative symptoms or cognitive dysfunction. In other cases, patients have drug-related adverse effects. The vasoactive intestinal peptide receptor 2 (VIPR2, also known as VPAC2 receptor) might be an attractive drug target for the treatment of schizophrenia because both clinical and preclinical studies have demonstrated a strong link between high expression/overactivation of VIPR2 and schizophrenia. Despite these backgrounds, the proof-of-concept of VIPR2 inhibitors has not been examined clinically. A reason might be that VIPR2 belongs to class-B GPCRs, and the discovery of small-molecule drugs against class-B GPCRs is generally difficult. We have developed a bicyclic peptide KS-133, which shows VIPR2 antagonist activity and suppresses cognitive decline in a mouse model relevant to schizophrenia. KS-133 has a different MOA from current therapeutic drugs and exhibits high selectivity for VIPR2 and potent inhibitory activity against a single-target molecule. Therefore, it may contribute to both the development of a novel drug candidate for the treatment of psychiatric disorders such as schizophrenia and acceleration of basic studies on VIPR2.
    MeSH term(s) Mice ; Animals ; Receptors, Vasoactive Intestinal Peptide, Type II ; Schizophrenia/drug therapy ; Vasoactive Intestinal Peptide/pharmacology ; Vasoactive Intestinal Peptide/therapeutic use
    Chemical Substances Receptors, Vasoactive Intestinal Peptide, Type II ; Vasoactive Intestinal Peptide (37221-79-7) ; Vipr2 protein, mouse
    Language Japanese
    Publishing date 2023-03-29
    Publishing country Japan
    Document type English Abstract ; Journal Article
    ZDB-ID 1097532-9
    ISSN 1347-8397 ; 0015-5691
    ISSN (online) 1347-8397
    ISSN 0015-5691
    DOI 10.1254/fpj.22146
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Roles of the monoaminergic system in the antidepressant effects of ketamine and its metabolites.

    Ago, Yukio / Yokoyama, Rei / Asano, Satoshi / Hashimoto, Hitoshi

    Neuropharmacology

    2022  Volume 223, Page(s) 109313

    Abstract: While the molecular target of (R,S)-ketamine (ketamine) is thought to be the NMDA receptor, subanesthetic doses of ketamine have been known to modulate monoaminergic neurotransmission in the central nervous system. Although the involvement of the ... ...

    Abstract While the molecular target of (R,S)-ketamine (ketamine) is thought to be the NMDA receptor, subanesthetic doses of ketamine have been known to modulate monoaminergic neurotransmission in the central nervous system. Although the involvement of the serotonergic system in the antidepressant effects of ketamine has been reported in most studies of this topic, some recent studies have reported that the dopaminergic system plays a key role in the effects of ketamine. Additionally, several lines of evidence suggest that the antidepressant-like effects of (R)-ketamine might be independent of the monoaminergic system. Ketamine metabolites also differ considerably in their ability to regulate monoamine neurotransmitters relative to (S)-ketamine and (R)-ketamine, while (2R,6R)-hydroxynorketamine might share common serotonergic signaling mechanisms with ketamine. In the current review, we summarize the effects of ketamine and its metabolites on monoamine neurotransmission in the brain and discuss the potential roles of the monoaminergic system in the mechanism of action of ketamine.
    Language English
    Publishing date 2022-10-31
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 218272-5
    ISSN 1873-7064 ; 0028-3908
    ISSN (online) 1873-7064
    ISSN 0028-3908
    DOI 10.1016/j.neuropharm.2022.109313
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: AlphaFold version 2.0 elucidates the binding mechanism between VIPR2 and KS-133, and reveals an S-S bond (Cys

    Sakamoto, Kotaro / Asano, Satoshi / Ago, Yukio / Hirokawa, Takatsugu

    Biochemical and biophysical research communications

    2022  Volume 636, Issue Pt 1, Page(s) 10–16

    Abstract: The vasoactive intestinal peptide receptor 2 (VIPR2) has attracted attention as a drug target for the treatment of mental disorders, cancer, and immune diseases. In 2021, we identified the peptide KS-133 as a VIPR2-selective antagonist. In this study, we ...

    Abstract The vasoactive intestinal peptide receptor 2 (VIPR2) has attracted attention as a drug target for the treatment of mental disorders, cancer, and immune diseases. In 2021, we identified the peptide KS-133 as a VIPR2-selective antagonist. In this study, we aimed to elucidate the binding mechanism between VIPR2 and KS-133. To this end, VIPR2/KS-133 and VIPR2/vasoactive intestinal peptide (VIP) complex models were constructed through AlphaFold version 2.0 and molecular dynamic simulations. Our models revealed that: (i) both KS-133 and VIP have helical structures, (ii) the interaction residues on VIPR2 for both peptides are similar, and (iii) the orientation of their helices upon their binding to VIPR2 are different by ∼45°. Interestingly, in the process of constructing the aforementioned models, an S-S bond formation between Cys
    MeSH term(s) Humans ; Mice ; Animals ; Receptors, Vasoactive Intestinal Peptide, Type II ; Receptors, Vasoactive Intestinal Peptide/metabolism ; Vasoactive Intestinal Peptide/metabolism ; Cell Line
    Chemical Substances Receptors, Vasoactive Intestinal Peptide, Type II ; Receptors, Vasoactive Intestinal Peptide ; Vasoactive Intestinal Peptide (37221-79-7) ; VIPR2 protein, human ; Vipr2 protein, mouse
    Language English
    Publishing date 2022-10-23
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 205723-2
    ISSN 1090-2104 ; 0006-291X ; 0006-291X
    ISSN (online) 1090-2104 ; 0006-291X
    ISSN 0006-291X
    DOI 10.1016/j.bbrc.2022.10.071
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Phospholipase C-related catalytically inactive protein enhances cisplatin-induced apoptotic cell death.

    Asano, Satoshi / Maetani, Yuka / Ago, Yukio / Kanematsu, Takashi

    European journal of pharmacology

    2022  Volume 933, Page(s) 175273

    Abstract: Cisplatin is one of the most widely used chemotherapeutic agents and induces caspase-9-mediated apoptosis. Here, we examined whether phospholipase C-related catalytically inactive protein (PRIP) enhances cisplatin-induced apoptosis of breast cancer cells. ...

    Abstract Cisplatin is one of the most widely used chemotherapeutic agents and induces caspase-9-mediated apoptosis. Here, we examined whether phospholipase C-related catalytically inactive protein (PRIP) enhances cisplatin-induced apoptosis of breast cancer cells. PRIP depletion increased expression of X-linked inhibitor of apoptosis protein (XIAP) by inhibiting protein degradation, which is downstream of the phosphatidylinositol 3-kinase/AKT pathway and inhibits apoptotic signaling by blocking caspase-9 activation. Conversely, the viability of MCF-7 cells transfected with Prip1 was significantly lower than that of control cells in the presence of cisplatin. The number of apoptotic nuclei and expression levels of cleaved caspase-9 and downstream cleaved caspase-7 and poly-ADP ribose polymerase were greater in PRIP1-expressing MCF-7 cells treated with cisplatin than in control cells. XIAP was decreased by expression of pleckstrin homology domain of PRIP1 (PRIP1-PH domain) that blocked phosphatidylinositol 4,5 bisphosphate metabolism. In an orthotopic transplantation model, combined administration of PRIP1-PH domain-containing liposomes and cisplatin reduced the size of MCF-7 tumors compared with cisplatin alone. Our findings demonstrate that PRIP promotes XIAP degradation by inhibiting PI(3,4,5)P
    MeSH term(s) Adenosine Diphosphate Ribose ; Apoptosis ; Caspase 7/metabolism ; Caspase 9/metabolism ; Cell Line, Tumor ; Cisplatin/pharmacology ; Humans ; Liposomes ; Phosphatidylinositol 3-Kinases/metabolism ; Phosphatidylinositols ; Proto-Oncogene Proteins c-akt/metabolism ; Type C Phospholipases/metabolism ; X-Linked Inhibitor of Apoptosis Protein/genetics ; X-Linked Inhibitor of Apoptosis Protein/metabolism
    Chemical Substances Liposomes ; Phosphatidylinositols ; X-Linked Inhibitor of Apoptosis Protein ; Adenosine Diphosphate Ribose (20762-30-5) ; Proto-Oncogene Proteins c-akt (EC 2.7.11.1) ; Type C Phospholipases (EC 3.1.4.-) ; Caspase 7 (EC 3.4.22.-) ; Caspase 9 (EC 3.4.22.-) ; Cisplatin (Q20Q21Q62J)
    Language English
    Publishing date 2022-09-13
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 80121-5
    ISSN 1879-0712 ; 0014-2999
    ISSN (online) 1879-0712
    ISSN 0014-2999
    DOI 10.1016/j.ejphar.2022.175273
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: [Transitive inference task in mice using a touchscreen assay].

    Ago, Yukio

    Nihon yakurigaku zasshi. Folia pharmacologica Japonica

    2014  Volume 144, Issue 1, Page(s) 45

    MeSH term(s) Animals ; Behavior, Animal ; Computers ; Disease Models, Animal ; Mice ; Translational Medical Research
    Language Japanese
    Publishing date 2014-05-13
    Publishing country Japan
    Document type Journal Article
    ZDB-ID 1097532-9
    ISSN 1347-8397 ; 0015-5691
    ISSN (online) 1347-8397
    ISSN 0015-5691
    DOI 10.1254/fpj.144.45
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: [Haploinsufficiency of the T-box transcription factor Tbr1].

    Ago, Yukio

    Nihon yakurigaku zasshi. Folia pharmacologica Japonica

    2014  Volume 144, Issue 3, Page(s) 146

    MeSH term(s) Animals ; Haploinsufficiency ; Mice ; T-Box Domain Proteins/genetics
    Chemical Substances T-Box Domain Proteins ; Tbx1 protein, mouse
    Language Japanese
    Publishing date 2014-05-13
    Publishing country Japan
    Document type Journal Article
    ZDB-ID 1097532-9
    ISSN 1347-8397 ; 0015-5691
    ISSN (online) 1347-8397
    ISSN 0015-5691
    DOI 10.1254/fpj.144.146
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Probing the

    Ago, Yukio / Asano, Satoshi / Hashimoto, Hitoshi / Waschek, James A

    Frontiers in neuroscience

    2021  Volume 15, Page(s) 717490

    Abstract: Pituitary adenylate cyclase-activating polypeptide (PACAP, gene ... ...

    Abstract Pituitary adenylate cyclase-activating polypeptide (PACAP, gene name
    Language English
    Publishing date 2021-07-22
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2411902-7
    ISSN 1662-453X ; 1662-4548
    ISSN (online) 1662-453X
    ISSN 1662-4548
    DOI 10.3389/fnins.2021.717490
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: [Neurochemical basis for social encounter-induced hyperactivity in post-weaning isolation-reared mice].

    Ago, Yukio

    Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology

    2014  Volume 34, Issue 4, Page(s) 101–107

    Abstract: Rearing rodents in social isolation from post-weaning causes abnormal behaviors in adulthood, such as hyper-locomotion, aggression, cognitive impairments, and depression- and anxiety-like behaviors. This social isolation is widely used as a model to ... ...

    Abstract Rearing rodents in social isolation from post-weaning causes abnormal behaviors in adulthood, such as hyper-locomotion, aggression, cognitive impairments, and depression- and anxiety-like behaviors. This social isolation is widely used as a model to study the effects of adverse early-life experiences on behavior and the neural mechanisms associated with neuropsychological development. Previous studies have shown abnormalities of dendritic spine density, synaptic protein levels and amine metabolism in the prefrontal cortex and hippocampus of isolation-reared animals, but the neurochemical basis for induction of abnormal behaviors is not known. We have established a novel methodology for assessing social interaction, focusing on the psychological stressor responsible for induction of abnormal behaviors as a transient environmental factor. This review summarizes the effect of a social encounter with an unfamiliar conspecific on behavior and neurochemistry in isolation-reared mice. The current analysis using the encounter response will provide new strategies to clarify the pathophysiology of psychiatric disorders including schizophrenia, depression and drug dependence.
    MeSH term(s) Animals ; Behavior, Animal ; Mice ; Psychomotor Agitation/psychology ; Social Behavior ; Social Isolation ; Stress, Psychological
    Language Japanese
    Publishing date 2014-08
    Publishing country Japan
    Document type English Abstract ; Journal Article ; Review
    ZDB-ID 1285665-4
    ISSN 1340-2544
    ISSN 1340-2544
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top